Reuters logo
Warburg Pincus to invest up to $300 mln in Vertice Pharma
2015年11月17日 / 晚上9点10分 / 2 年前

Warburg Pincus to invest up to $300 mln in Vertice Pharma

NEW YORK, Nov 17 (Reuters) - Private equity firm Warburg Pincus LLC said on Tuesday it had agreed to invest up to $300 million in Vertice Pharma, a British pharmaceuticals company that will focus on buying drug makers and their products.

Vertice Pharma will be a partnership between Warburg Pincus and two pharmaceutical executives, the private equity firm said in a statement.

Among its first acquisitions, Vertice has struck a deal to buy VistaPharm, a specialized manufacturer of pain medication, Warburg Pincus said, without disclosing the details of the transaction.

Based in New York, Warburg Pincus manages over $35 billion worth of assets. (Reporting by Koh Gui Qing in New York; Editing by Alan Crosby)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below